Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pediatric Endocrinology

Lab Tests, The Critical Sample, and Genetics

At a Glance

HI/HA syndrome is evaluated during a supervised low blood sugar episode: a critical sample checks whether insulin remains active and suppresses ketones and fatty acids, while genetic testing looks for GLUD1 and related gene changes. Normal ammonia does not exclude the condition.

Confirming a diagnosis of HI/HA syndrome requires more than just a single blood sugar check. Because the body’s chemistry changes rapidly during a “low,” doctors must capture a snapshot of your child’s metabolic state at the exact moment their blood sugar is dropping [1]. This specialized blood draw is known as the critical sample [2].

Note: Families should never provoke a fast or wait for a particular number to obtain a critical sample at home. This must only be done under strict medical supervision.

The Critical Sample: A Metabolic Snapshot

When blood sugar falls below a certain threshold—often considered around 50 mg/dL (2.8 mmol/L) in many laboratory protocols, though specific cutoffs vary by hospital—a healthy body should turn off insulin and start burning fat for fuel [2][1]. In children with HI/HA, the critical sample reveals that the body is doing the opposite: it is still acting as if it has plenty of sugar [3].

To confirm the diagnosis, doctors look for several specific markers in that one blood draw. Exact numerical cutoffs vary by laboratory and assay, but they generally include:

  • Inappropriate Insulin or C-peptide: Even a small amount of insulin (e.g., above 1.25 μU/mL) or C-peptide (e.g., above 0.5 ng/mL) during a low is “inappropriate” [4][3]. However, it is important to know that insulin can sometimes be low or undetectable even when insulin action is excessive.
  • Low Ketones and Fatty Acids: When the body burns fat for fuel, it creates ketones (specifically beta-hydroxybutyrate) and free fatty acids [3]. In HI/HA, insulin blocks this process. If these levels are very low (e.g., beta-hydroxybutyrate below 1.8–2.0 mmol/L), it is a major clue that insulin is interfering [3][4].
  • The Glucagon Response: As part of the test, doctors may give an injection of glucagon under supervision. In a child with HI/HA, this will cause a sharp rise in blood sugar (often at least 30 mg/dL) because the body has “trapped” sugar in the liver that it couldn’t release [3].

Common Components for Diagnosis

A thorough diagnostic workup should include more than just blood sugar. Use this list to understand what your team is testing:

  1. Plasma Glucose: Measured at the laboratory at the same time as all other markers [1].
  2. Insulin & C-peptide: To confirm the pancreas is overactive [3].
  3. Beta-hydroxybutyrate (BHB): To check for suppressed ketones [3].
  4. Free Fatty Acids (FFA): To check for suppressed fat-burning [4].
  5. Ammonia Levels: Often persistently high in HI/HA, though normal levels do not rule out the disease [5][6].
  6. Glucagon Stimulation Test: To see if the liver is holding onto sugar [3].
  7. Differential Testing: Tests like cortisol, growth hormone, lactate, acylcarnitines, and urine organic acids are also often evaluated to rule out other metabolic conditions.

The Importance of Multigene Panels

Once the metabolic tests point toward hyperinsulinism, genetic testing is the next step. While HI/HA is caused by the GLUD1 gene, it is essential to use a multigene panel rather than testing for just one gene [7].

A panel looks at many genes at once, including ABCC8, KCNJ11, and GCK, which can cause similar symptoms [8]. This is important because the treatment and the “rules” for the disease (like whether protein is a trigger) change depending on which gene is involved [9]. A comprehensive panel should also include copy-number analysis to find larger pieces of missing or extra DNA that standard tests might miss [10].

When Testing is “Negative”: The Role of Mosaicism

Sometimes, a child has every symptom of HI/HA, but their genetic test comes back negative. This does not automatically mean the diagnosis is wrong.

A negative blood panel should lead to a review of the variant quality and classification by your genetics team, and potentially broader exome/genome testing or a formal genetics consultation. In rare cases, this can happen because of mosaicism [11]. In mosaicism, the mutation is only present in some cells, while the rest of the body (including the blood being tested) is normal [11]. While pancreatic mosaicism is seen in some focal congenital hyperinsulinism forms, typical GLUD1-related HI/HA is generally caused by a heterozygous germline variant [11]. If your child’s blood test is negative but their symptoms strongly match HI/HA, your doctor may suggest more sensitive testing to look for these “hidden” mutations [12][11].

Common questions in this guide

What is a critical sample for HI/HA syndrome?
A critical sample is a set of blood tests collected while a child is having low blood sugar. It measures glucose, insulin or C-peptide, ketones, fatty acids, ammonia, and other markers to show whether insulin is still blocking the body’s normal response. It must be collected under medical supervision, never by making a child fast at home.
Which critical-sample results point to HI/HA syndrome?
The pattern usually includes insulin or C-peptide that is not appropriately suppressed, very low ketones and free fatty acids, and a rise in blood sugar after supervised glucagon. Exact thresholds vary by laboratory, so the full pattern and clinical context matter more than one number.
Can a normal ammonia level rule out HI/HA syndrome?
No. Ammonia is often persistently high in HI/HA syndrome, but it can be normal, so a normal result does not exclude the diagnosis. Doctors interpret ammonia alongside the critical-sample findings and the child’s history.
Why is a multigene panel used instead of testing GLUD1 alone?
HI/HA syndrome is linked to GLUD1, but other genes such as ABCC8, KCNJ11, and GCK can cause similar low blood sugar patterns. A broad panel can identify the responsible gene and may include testing for larger missing or extra DNA segments, which can affect diagnosis and care.
What does a negative genetic test mean if my child still has signs of HI/HA?
A negative blood test does not always end the evaluation. The genetics team may review the variant analysis, consider broader exome or genome testing, or look for mosaicism, in which a gene change is present in some cells but not others. The result should be interpreted with the metabolic findings.
Is it safe to wait for low blood sugar to collect a critical sample at home?
No. Families should not fast a child, delay treatment, or try to create low blood sugar at home for testing. A critical sample and glucagon test must be planned and performed by a medical team that can treat hypoglycemia immediately.

Get notified when new evidence is published on Hyperinsulinism-hyperammonemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism.

    Siersbæk J, Larsen AR, Nybo M, Christesen HT

    Frontiers in endocrinology 2020; (11()):614993 doi:10.3389/fendo.2020.614993.

    PMID: 33679602
  2. 2

    Congenital Hyperinsulinaemic Hypoglycaemia-A Review and Case Presentation.

    Krawczyk S, Urbanska K, Biel N, et al.

    Journal of clinical medicine 2022; (11(20)) doi:10.3390/jcm11206020.

    PMID: 36294341
  3. 3

    Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children.

    Ferrara C, Patel P, Becker S, et al.

    The Journal of pediatrics 2016; (168()):212-219 doi:10.1016/j.jpeds.2015.09.045.

    PMID: 26490124
  4. 4

    Diagnosis of congenital hyperinsulinism: Biochemical profiles during hypoglycemia.

    Sakakibara A, Hashimoto Y, Kawakita R, et al.

    Pediatric diabetes 2018; (19(2)):259-264 doi:10.1111/pedi.12548.

    PMID: 28597971
  5. 5

    Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.

    De Los Santos-La Torre MA, Del Águila-Villar CM, Lu-de Lama LR, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(2)):207-211 doi:10.1515/jpem-2022-0490.

    PMID: 36476334
  6. 6

    Clinical and Molecular Spectrum of Glutamate Dehydrogenase Gene Defects in 26 Chinese Congenital Hyperinsulinemia Patients.

    Su C, Liang XJ, Li WJ, et al.

    Journal of diabetes research 2018; (2018()):2802540 doi:10.1155/2018/2802540.

    PMID: 30306091
  7. 7

    Comprehensive genetic rescreening improves diagnostic yield in congenital hyperinsulinism.

    Männistö JME, Houghton JAL, Bennett JJ, et al.

    Journal of the Endocrine Society 2026; (10(4)):bvag047 doi:10.1210/jendso/bvag047.

    PMID: 41924297
  8. 8

    Congenital Hyperinsulinism: Current Laboratory-Based Approaches to the Genetic Diagnosis of a Heterogeneous Disease.

    Hewat TI, Johnson MB, Flanagan SE

    Frontiers in endocrinology 2022; (13()):873254 doi:10.3389/fendo.2022.873254.

    PMID: 35872984
  9. 9

    Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.

    Stanley CA

    The Journal of clinical endocrinology and metabolism 2016; (101(3)):815-26 doi:10.1210/jc.2015-3651.

    PMID: 26908106
  10. 10

    Large copy number variants are an important cause of congenital hyperinsulinism that should be screened for during routine testing.

    Flanagan SE, Lazaridi IA, Männistö JME, et al.

    Frontiers in endocrinology 2025; (16()):1514916 doi:10.3389/fendo.2025.1514916.

    PMID: 40041288
  11. 11

    Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome.

    Boodhansingh KE, Rosenfeld E, Lord K, et al.

    Hormone research in paediatrics 2022; (95(5)):492-498 doi:10.1159/000526203.

    PMID: 35952631
  12. 12

    Low-level mosaic variants causing the pancreatic disease congenital hyperinsulinism can be detected from blood DNA.

    Bennett JJ, Laver TW, Männistö JME, et al.

    EBioMedicine 2026; (128()):106308 doi:10.1016/j.ebiom.2026.106308.

    PMID: 42184599

This page explains critical samples and genetic testing for HI/HA syndrome for informational purposes only and does not constitute medical advice. Never try to trigger a low blood sugar at home; ask your child’s metabolic or endocrine team to interpret test results.